| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/12/2005 | EP1495111A2 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells |
| 01/12/2005 | EP1495053A2 Angiopoietin-2 specific binding agents |
| 01/12/2005 | EP1495051A1 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells |
| 01/12/2005 | EP1495046A2 Selective melanin concentrating hormone type 1 receptor agonists |
| 01/12/2005 | EP1495044A1 Heterocyclic amides with alpha-4 integrin antagonist activity |
| 01/12/2005 | EP1495034A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses |
| 01/12/2005 | EP1495030A1 Non-steroidal progesterone receptor modulators |
| 01/12/2005 | EP1495023A1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same |
| 01/12/2005 | EP1495018A1 Tricyclic thrombin receptor antagonists |
| 01/12/2005 | EP1495016A2 Heterocyclic compounds and their use as modulators of p38 map kinase |
| 01/12/2005 | EP1495014A2 Novel flavanoids and chalcones as chemotherapeutic, chemopreventive, and antiangiogenic agents |
| 01/12/2005 | EP1495006A1 Inhibitors of glycinamide ribonucleotide transformylase |
| 01/12/2005 | EP1495005A1 Pyrazole compounds as anti-inflammatory and analgesic agents |
| 01/12/2005 | EP1495003A1 Fredericamycin derivatives |
| 01/12/2005 | EP1495002A1 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/12/2005 | EP1495000A1 Alpha, omega-dicarboximide derivatives as useful uro-selective a1a adrenoceptor blockers |
| 01/12/2005 | EP1494999A1 Occlusive composition comprising a poly(2-cyanoacrylate) monomer |
| 01/12/2005 | EP1494993A2 Novel curcumin analogues and uses thereof |
| 01/12/2005 | EP1494992A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 01/12/2005 | EP1494989A2 Compounds that modulate ppar activity and methods for their preparation |
| 01/12/2005 | EP1494752A1 Method of treating biological materials with translating electrical fields and electrode polarity reversal |
| 01/12/2005 | EP1494718A1 Combination of an agent that attenuates topoisomerase i activity and an agent that inhibits heat shock protein 90 for use in chemotherapy |
| 01/12/2005 | EP1494716A2 Use of substances for treating tumors |
| 01/12/2005 | EP1494709A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/12/2005 | EP1494705A1 A composition and method for killing of tumours |
| 01/12/2005 | EP1494698A2 Compositions and methods for treating and preventing necrosis |
| 01/12/2005 | EP1494693A2 Cripto-specific antibodies |
| 01/12/2005 | EP1494683A1 Method for inhibiting bone resorption with an alendronate and vitamin d formulation |
| 01/12/2005 | EP1494676A1 Fused quinoxaline derivatives as inhibitors of akt activity |
| 01/12/2005 | EP1494672A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity |
| 01/12/2005 | EP1494670A1 Medicine for treating cancer |
| 01/12/2005 | EP1494668A2 Use of benzimidazole analogs in the treatment of cell proliferation |
| 01/12/2005 | EP1494667A1 Imidazole compounds as anti-inflammatory and analgesic agents |
| 01/12/2005 | EP1494662A1 Tnp-470 polymer conjugates and use thereof |
| 01/12/2005 | EP1494649A1 Nanoparticulate megestrol formulations |
| 01/12/2005 | EP1494613A2 Potent oncolytic herpes simplex virus for cancer therapy |
| 01/12/2005 | EP1443970A4 Promoters exhibiting endothelial cell specificity and methods of using same |
| 01/12/2005 | EP1365781A4 Acrochordon alleviation |
| 01/12/2005 | EP1307216A4 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 01/12/2005 | EP1259502B1 Biologically active analogs of discodermolide |
| 01/12/2005 | EP1233023B1 Transcription factor and dna thereof |
| 01/12/2005 | EP1194044B1 Pharmaceutical or dietetic mushroom-based compositions and their use |
| 01/12/2005 | EP1183254B1 Substituted bicyclic heteroaryl compounds as integrin antagonists |
| 01/12/2005 | EP1183228B1 Esters of l-carnitine or alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds. |
| 01/12/2005 | EP1089713B1 Temperature-sensitive liposomal formulation |
| 01/12/2005 | EP1002082B1 Transcriptional silencer protein nrf |
| 01/12/2005 | EP0991628B1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56lck TYROSINE KINASES |
| 01/12/2005 | CN1564829A Antibodies to insulin-like growth factor I receptor |
| 01/12/2005 | CN1564826A Human G-protein chemokine receptor (CCR5) HDGNR10 |
| 01/12/2005 | CN1564822A Antitumoral analogs |
| 01/12/2005 | CN1564811A Acylsulfonamides as inhibitors of steroid sulfatase |
| 01/12/2005 | CN1564690A Tetracycline derivatives and methods of use thereof |
| 01/12/2005 | CN1564689A Oral pharmaceutical products containing 17beta-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
| 01/12/2005 | CN1564687A Use of phosphodiesterase IV inhibitors |
| 01/12/2005 | CN1564685A Pyrrolidinone derivatives |
| 01/12/2005 | CN1564678A Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 01/12/2005 | CN1563391A Recombined expression vector of restraining multiplication of leukemia cell |
| 01/12/2005 | CN1563390A Common expression vector between 2 subtype receptor of human somatotropin release in hibiting factor and cytosine deaminease of colibacillus, establishment and application |
| 01/12/2005 | CN1563381A Deactivated protein gene in ribosome of motherwort |
| 01/12/2005 | CN1563092A Recombining single chained three specific antibodies of anti CCA, anti CD 3, anti CD 28 through genetic engineering |
| 01/12/2005 | CN1563079A Adherence peptide specific to tissue of liver cancer obtained through sieve method in vitro, and usage |
| 01/12/2005 | CN1563078A Adherence peptide specific to tissue of liver cancer, screen method combined between in vivo and in vitro, and usage |
| 01/12/2005 | CN1563077A Adherence peptide specific to tissue of liver cancer obtained through sieve method in rivo, and usage |
| 01/12/2005 | CN1563023A 3, 6-bi(2'-hydroxy-5'-chlorphenyl)-S-tetrazine and accessory ingredient of transition metal, preparation and application |
| 01/12/2005 | CN1563011A Compounds of podophyllotoxins, application and preparation method |
| 01/12/2005 | CN1562971A Radioactive rhenium-N-accessory ingredient of alkyl dinitrogen disulfide for curing liver cancer and preparation method |
| 01/12/2005 | CN1562375A Combination of medication produced from attenuated salmonella bacteria possessing effect of radiation protection and anti tumour |
| 01/12/2005 | CN1562363A Polypeptide vaccine of free from adjuvant for anti human chorionic gonadotrophin and preparation method |
| 01/12/2005 | CN1562361A Compound pefusion for anti bladder cancer |
| 01/12/2005 | CN1562338A Injection for anti tumour prepared from ganoderma lucidum and method of preparing trial-products provided |
| 01/12/2005 | CN1562335A Essential oil of ganoderma lucidum spore and preparation technique |
| 01/12/2005 | CN1562332A Preparation of spirulina tablet |
| 01/12/2005 | CN1562288A Chinese traditional medicine for curing cardiovascular and cerebrovascular diseases |
| 01/12/2005 | CN1562270A Anticancer drugs of injection of freeze drying powder and large infusion solution extracted from Caulis Marsdeniae Tenacissimae and preparation method |
| 01/12/2005 | CN1562242A Capsule of burnet for raising white cell and preparation method |
| 01/12/2005 | CN1562208A Medication for treating malignant tumor and preparation method |
| 01/12/2005 | CN1562177A Chinese materia medica preparation for treating hysteromyoma and preparation method |
| 01/12/2005 | CN1562174A Injection emulsion of oil of zedoary turmeric, and preparation method |
| 01/12/2005 | CN1562163A Anti-cancer Chinese medicinal composition and its preparing method |
| 01/12/2005 | CN1562162A Chinese medicine composition for curing cancer and its preparing method |
| 01/12/2005 | CN1562147A Radix scutellariae extract freeze-dried powder injection and its preparing method |
| 01/12/2005 | CN1562129A Seabuckthora fruit and lucid ganoderma nutrition mixture with auxiliary anti-cancer function |
| 01/12/2005 | CN1562108A Rosa roxburghii bee jelly anti-cancer honey milk |
| 01/12/2005 | CN1562101A Rosa roxburghii oral liquid and its preparing method |
| 01/12/2005 | CN1562091A Medicine for treating leukaemia |
| 01/12/2005 | CN1562088A Oral adminitration Chinese medicine for treating lung cancer |
| 01/12/2005 | CN1562073A Non-injection preparation containing medium and/or low molecular weight chondroitin sulfate |
| 01/12/2005 | CN1562070A Medicine for treating leukopenia and its preparing method |
| 01/12/2005 | CN1562022A Compound for treating leukemia and multiple myeloma |
| 01/12/2005 | CN1562021A Method for improving liposome enveloping rate of camptothecine or its derivatives |
| 01/12/2005 | CN1562006A Leucogen oral disintegration tablet and its preparing method |
| 01/12/2005 | CN1562002A Novel anti-biological cell free redical oxidation injury mixture |
| 01/12/2005 | CN1561995A Norcuntharidin soft capsule and its preparing method |
| 01/12/2005 | CN1561990A Treatment of immune diseases |
| 01/12/2005 | CN1561988A Method for preparing taxol micro ball anti-cancer medicine |
| 01/12/2005 | CN1561987A Nano micro ball with taxol capable of biologically degradating high molecule and its preparing method |
| 01/12/2005 | CN1561968A Antibody and polyalkylene glycol-bonded liposome |
| 01/12/2005 | CN1184321C Adenovirus-mediated gene therapy |
| 01/12/2005 | CN1184320C Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment |
| 01/12/2005 | CN1184316C Antisense oligonucleotide structure and use of cell propagation receptor IGFIK |